Find therapies in clinical trials near you – page 6

Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk

Study on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure

Study on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure

Study on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis

Study on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis

Study on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen

Study on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen

Long-term safety study of tulisokibart in adults with Crohn's disease or ulcerative colitis

Long-term safety study of tulisokibart in adults with Crohn's disease or ulcerative colitis

Study comparing rilvegostomig plus chemotherapy versus pembrolizumab plus chemotherapy for first-line treatment in patients with metastatic non-squamous lung cancer with PD-L1 expression

Study comparing rilvegostomig plus chemotherapy versus pembrolizumab plus chemotherapy for first-line treatment in patients with metastatic non-squamous lung cancer with PD-L1 expression

Study of IPH5201 and Durvalumab for Pre- and Post-Surgery Treatment in Patients with Early-Stage Non-Small Cell Lung Cancer

Study of IPH5201 and Durvalumab for Pre- and Post-Surgery Treatment in Patients with Early-Stage Non-Small Cell Lung Cancer

Study on the Effects of Obicetrapib and Ezetimibe on Coronary Plaque in Patients with Atherosclerotic Cardiovascular Disease

Study on the Effects of Obicetrapib and Ezetimibe on Coronary Plaque in Patients with Atherosclerotic Cardiovascular Disease

Study on Lebrikizumab for Adults with Chronic Rhinosinusitis and Nasal Polyps Using Intranasal Corticosteroids

Study on Lebrikizumab for Adults with Chronic Rhinosinusitis and Nasal Polyps Using Intranasal Corticosteroids

Study on Anifrolumab for Adults with Polymyositis or Dermatomyositis

Study on Anifrolumab for Adults with Polymyositis or Dermatomyositis

Study on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction

Study on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction

Study of Pegozafermin Treatment for Patients with Liver Cirrhosis due to Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Study of Pegozafermin Treatment for Patients with Liver Cirrhosis due to Metabolic Dysfunction-Associated Steatohepatitis (MASH)